5 Stocks On Investors’ Radar After Earnings Reports

1. Pfizer Inc. (NYSE:PFE)

Number of Hedge Fund Holders: 74

Pfizer Inc. (NYSE:PFE) recently announced a better-than-expected profit for the fourth quarter. However, its quarterly sales fell below expectations, sending its shares down nearly three percent on Tuesday, February 8, 2022.

The New York-based pharmaceutical giant earned $1.08 per share on an adjusted basis, representing a surge of more than two folds versus the year-ago period. It also crushed the consensus forecast of 87 cents per share.

Revenue for the quarter also skyrocketed 105 percent on a year-over-year basis to $23.84 billion, mainly driven by sales of its coronavirus vaccine. However, analysts were expecting Pfizer Inc. (NYSE:PFE) to generate revenue of $24.16 billion

Looking forward, Pfizer Inc. (NYSE:PFE) expects adjusted earnings in the range of $6.35 – $6.55 per share and revenue between $98 – $102 billion for 2022. But the outlook fell short of analysts’ average estimate of $6.71 per share for earnings and $103.2 billion for revenue.

Speaking on the results, CFO of Pfizer Inc. (NYSE:PFE), Frank D’Amelio,, said in a statement:

“As I prepare to retire as CFO of Pfizer, I am proud to see that the company is performing better than at any other time during my nearly 15 years here. Today we are issuing guidance for the coming year which, if achieved, would represent the highest level of annual revenues and Adjusted diluted EPS in Pfizer’s long history.”

You can also take a peek at Early Retirement Portfolio: 15 Stocks to Live Off Dividends and Top 10 Stock Picks of Thomas Bancroft’s Makaira Partners.

Follow Insider Monkey on Twitter